TSE:BHC

Bausch Health Companies - BHC Stock Forecast, Price & News

C$9.56

-0.07 (-0.73%)

(As of 09/23/2022 12:00 AM ET)

Add

Compare

Today's Range: C$9.06
▼
C$9.60
50-Day Range: C$5.50
▼
C$11.83
52-Week Range: C$5.10
▼
C$37.38

Volume: 1.81 million shs
Average Volume: 1.02 million shs
Market Capitalization: C$3.46 billion

P/E Ratio: 50.32
Dividend Yield: N/A
Price Target: C$29.00

Bausch Health Companies MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 203.3% Upside
C$29.00 Price Target
Short Interest: N/A
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.29
Based on 12 Articles This Week
Insider Trading: Selling Shares
C$983,535 Sold Last Quarter
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.27 out of 5 stars

3.5

Analyst's Opinion

Consensus Rating
Bausch Health Companies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of C$29.00, Bausch Health Companies has a forecasted upside of 203.3% from its current price of C$9.56.
Amount of Analyst Coverage
Bausch Health Companies has received no research coverage in the past 90 days.

N/A

Short Interest

Short Interest
There is no current short interest data available for BHC.

0.0

Dividend Strength

Dividend Yield
Bausch Health Companies does not currently pay a dividend.
Dividend Growth
Bausch Health Companies does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for BHC.

1.8

News and Social Media Coverage

News Sentiment
Bausch Health Companies has a news sentiment score of 0.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 12 news articles for Bausch Health Companies this week, compared to 2 articles on an average week.
Search Interest
Only 39 people have searched for BHC on MarketBeat in the last 30 days. This is a decrease of -17% compared to the previous 30 days.
MarketBeat Follows
Only 1 people have added Bausch Health Companies to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

0.8

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Bausch Health Companies insiders have sold more of their company's stock than they have bought. Specifically, they have bought C$0.00 in company stock and sold C$983,535.00 in company stock.

2.5

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Bausch Health Companies is 50.32, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 114.36.
Price to Earnings Ratio vs. Sector
The P/E ratio of Bausch Health Companies is 50.32, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 83.19.
Price to Earnings Growth Ratio
Bausch Health Companies has a PEG Ratio of 0.63. PEG Ratios below 1 indicate that a company could be undervalued.

See Top Rated MarketRank™ Stocks Here

About Bausch Health Companies (TSE:BHC) Stock

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Receive BHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bausch Health Companies and its competitors with MarketBeat's FREE daily newsletter.

BHC Stock News Headlines

September 23, 2022 | ca.finance.yahoo.com

Bausch Health and Glenmark Announce the approval of RYALTRIS® in Canada

September 22, 2022 | finance.yahoo.com

Paris Opera Ballet’s Cri de cœur — a three-hour collage of nervous breakdowns

September 21, 2022 | seekingalpha.com

Bausch Health Companies: Equity Stub Would Benefit From Ambitious Spinoff

September 20, 2022 | theglobeandmail.com

Bausch Health Companies: Top 25 Undervalued Toronto Stock Exchange Stocks (BHC)

September 17, 2022 | americanbankingnews.com

Bausch Health Companies Inc. (TSE:BHC) Director Joseph Papa Sells 100,000 Shares of Stock

September 9, 2022 | nasdaq.com

Bausch Health Comments On Tentative FDA Approval Of Generic Version Of Antibiotic Xifaxan

September 8, 2022 | finance.yahoo.com

Why Is Bausch (BHC) Up 23% Since Last Earnings Report?

September 5, 2022 | msn.com

Why Bausch Health Stock Has Risen 44% in the Last Month

September 2, 2022 | finance.yahoo.com

Why Shares of Bausch Health Rose as Much as 30.3% This Week

August 23, 2022 | wsj.com

Bausch Health Hires Advisers Amid Patent Loss, Spinoff Controversy

August 15, 2022 | finance.yahoo.com

Bausch (BHC) to Appeal Regarding Xifaxan Patent Decision

August 10, 2022 | finance.yahoo.com

Salix Supports CMS Announcement of First ICD-10 Code for Hepatic Encephalopathy (HE)

August 9, 2022 | msn.com

Recap: Bausch Health Companies Q2 Earnings

August 9, 2022 | seekingalpha.com

Bausch Health Companies Inc. (BHC) CEO Thomas Appio on Q2 2022 Results - Earnings Call Transcript

August 9, 2022 | finance.yahoo.com

Why Bausch Health Stock Tumbled More Than 11% on Tuesday

August 9, 2022 | nasdaq.com

Bausch Health Companies Inc. Q2 Earnings Summary

August 9, 2022 | seekingalpha.com

Bausch Health sheds 13% after Q2 revenue slump and guidance cut

August 9, 2022 | finance.yahoo.com

Bausch's stock slides 11.8% after announcing Q2 results

August 9, 2022 | finance.yahoo.com

Bausch Health Stock Sinks on Earnings Miss and Lowered Guidance

August 4, 2022 | nasdaq.com

September 23rd Options Now Available For Bausch Health Companies (BHC)

August 2, 2022 | finance.yahoo.com

What's in the Cards for Bausch Health (BHC) Q2 Earnings?

August 1, 2022 | finance.yahoo.com

Shareholders in Bausch Health Companies (NYSE:BHC) have lost 84%, as stock drops 47% this past week

July 30, 2022 | seekingalpha.com

Bausch Health: How To Price The Calamities

July 29, 2022 | finance.yahoo.com

Bausch (BHC) Loses 39% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

July 29, 2022 | finance.yahoo.com

Bausch Health stock tumbles toward lowest close since 1995 after confirming disappointing court ruling

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive BHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bausch Health Companies and its competitors with MarketBeat's FREE daily newsletter.

BHC Company Calendar

Last Earnings: 8/09/2022
Today: 9/25/2022
Next Earnings (Estimated): 11/01/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: TSE
Industry: Drug Manufacturers - Specialty & Generic
Sub-Industry: N/A
Sector: Medical
Current Symbol: TSE:BHC
CUSIP: N/A
CIK: N/A
Web: www.valeant.com
Phone: 514-744-6792
Fax: N/A
Employees: 19,600
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: C$29.00
High Stock Price Forecast: C$32.00
Low Stock Price Forecast: C$26.00
Forecasted Upside/Downside: +203.3%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: 50.32
Forward P/E Ratio: 1.55
P/E Growth: 0.63
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 8,622.13
Current Ratio: 1.08
Quick Ratio: 0.46

Sales & Book Value

Annual Sales: C$8.19 billion
Price / Sales: 0.42
Cash Flow: C$1.82 per share
Price / Cash Flow: 5.24
Book Value: C($1.92) per share
Price / Book: -4.99

Miscellaneous

Outstanding Shares: 361,728,000
Free Float: N/A
Market Cap: C$3.46 billion
Optionable: Optionable
Beta: N/A

Key Executives

Mr. Thomas J. Appio (Age 60)
CEO & Director
Comp: $2.9M

Mr. Thomas G. Vadaketh (Age 59)
Exec. VP & CFO

Mr. Mirza Dautbegovic
Sr. VP & COO

Mr. John S. Barresi (Age 49)
Sr. VP, Controller & Chief Accounting Officer

Dr. Robert F. Butz
VP of Medical & Scientific Affairs

Mr. Arthur J. Shannon
Sr. VP and Head of Investor Relations & Global Communications

Ms. Seana Carson (Age 50)
Exec. VP & Gen. Counsel

Ms. Kathleen Fitzpatrick
Sr. VP & Chief HR Officer

Dr. Tage Ramakrishna M.D. (Age 48)
Chief Medical Officer and Pres of R&D

Mr. Jeff Hartness
Sr. VP of Market Access, Commercial Operations & Gov. Affairs

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

BHC Stock - Frequently Asked Questions

Should I buy or sell Bausch Health Companies stock right now?: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Bausch Health Companies in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" BHC shares.
View BHC analyst ratings or view top-rated stocks.
What is Bausch Health Companies' stock price forecast for 2022?: 1 Wall Street analysts have issued 1 year price targets for Bausch Health Companies' stock. Their BHC share price forecasts range from C$26.00 to C$32.00. On average, they predict the company's stock price to reach C$29.00 in the next twelve months. This suggests a possible upside of 203.3% from the stock's current price.
View analysts price targets for BHC or view top-rated stocks among Wall Street analysts.
How have BHC shares performed in 2022?: Bausch Health Companies' stock was trading at C$34.94 at the beginning of 2022. Since then, BHC stock has decreased by 72.6% and is now trading at C$9.56.
View the best growth stocks for 2022 here.
When is Bausch Health Companies' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 1st 2022.
View our BHC earnings forecast.
How were Bausch Health Companies' earnings last quarter?: Bausch Health Companies Inc. (TSE:BHC) released its quarterly earnings results on Tuesday, August, 9th. The company reported $0.71 earnings per share for the quarter, missing analysts' consensus estimates of $1.15 by $0.44. The business had revenue of $2.51 billion for the quarter, compared to analysts' expectations of $2.63 billion.

What other stocks do shareholders of Bausch Health Companies own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Bausch Health Companies investors own include Chesapeake Energy (CHKAQ), Enbridge (ENB), Aurora Cannabis (ACB), Manulife Financial (MFC), BlackBerry (BB), Bank of Nova Scotia (BNS), Toronto-Dominion Bank (TD), Nutrien (NTR), Suncor Energy (SU) and ARC Resources (ARX).
What is Bausch Health Companies' stock symbol?: Bausch Health Companies trades on the Toronto Stock Exchange (TSX) under the ticker symbol "BHC."
How do I buy shares of Bausch Health Companies?: Shares of BHC stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.
What is Bausch Health Companies' stock price today?: One share of BHC stock can currently be purchased for approximately C$9.56.
How much money does Bausch Health Companies make?: Bausch Health Companies (TSE:BHC) has a market capitalization of C$3.46 billion and generates C$8.19 billion in revenue each year.
How many employees does Bausch Health Companies have?: The company employs 19,600 workers across the globe.
How can I contact Bausch Health Companies?: Bausch Health Companies' mailing address is 2150 Saint-Elzear Blvd W, Laval, Quebec H7L 4A8. The official website for the company is www.valeant.com. The company can be reached via phone at 514-744-6792.

This page (TSE:BHC) was last updated on 9/25/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial Subscription Here

Bausch Health Companies - BHC Stock Forecast, Price & News

Bausch Health Companies MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Short Interest

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Bausch Health Companies (TSE:BHC) Stock

BHC Stock News Headlines

BHC Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

BHC Stock - Frequently Asked Questions

MarketBeat Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources

Overall MarketRank^™